Website Overview: tagrissohcp.com
General information
Last Updated: 2024-04-09 (yyyy-mm-dd).
Title: Treatment for Resectable and Metastatic EGFRm NSCLC TAGRISSO osimertinib
Description: Learn about TAGRISSO osimertinib a targeted therapy for resectable EGFRm non small cell lung cancer NSCLC and the first line treatment of metastatic EGFRm NSCLC
Language: English
Contact information
Telephone
- 1-800-236-9933
Social Links
Related Websites
- azpicentral.com
- tagrisso.com
- astrazeneca-us.com
- astrazeneca.com
- azprivacynotice.com